Product Information
COLCRYS 0.6 MG TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $6.9085 per EA under NDC 64764011901. Its NADAC has been published 608 times since Nov 28, 2013.
FDA first approved this application on Jul 29, 2009.
The High Outlier badge above means this manufacturer's average price in the Colchicine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.6 mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
64764011901
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
COLCHICINEApproval Type
New Drug (NDA)
FDA Application
NDA022352FDA Approved
7/29/2009
On Market Since
9/1/2009
Pharmacological Classes
Price Statistics
The NADAC for COLCRYS 0.6 MG TABLET has been published 608 times since Nov 28, 2013, and over the history we have for it it has risen 38.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.9085 per EA |
|---|---|
| All-time high | $6.9200 (May 15, 2024) |
| All-time low | $4.9871 (Nov 28, 2013) |
| 52-week high | $6.9085 |
| 52-week low | $6.9085 |
| Median price | $6.6882 |
| Average price | $6.4977 |
| Largest weekly change | +9.9% (Apr 15, 2015) |
| Weeks tracked | 608 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
+0.2%
5Y
+0.1%
All
+38.5%
Last surveyed Feb 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Takeda Pharmaceuticals America, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Colchicine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Alkaloid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COLCRYS 0.6 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for COLCRYS 0.6 MG TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $6.9085 per EA (NDC 64764011901), effective Feb 11, 2026.
How has the price of COLCRYS 0.6 MG TABLET changed over time?
Over the history we have for it, the NADAC for COLCRYS 0.6 MG TABLET has risen 38.5%. It has been tracked across 608 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for COLCRYS 0.6 MG TABLET?
Since Nov 28, 2013, the NADAC for COLCRYS 0.6 MG TABLET has ranged from a low of $4.9871 (Nov 28, 2013) to a high of $6.9200 (May 15, 2024), with a median of $6.6882 per EA.
Are there cheaper alternatives to COLCRYS 0.6 MG TABLET?
Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, COLCHICINE 0.6 MG TABLET, is $0.1221 per EA — about 98% below COLCRYS 0.6 MG TABLET.
Who manufactures COLCRYS 0.6 MG TABLET?
COLCRYS 0.6 MG TABLET (NDC 64764011901) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.